Tag Archives: Cyramza

April, 2018

May, 2017

April, 2015

  • 27 April

    Lilly’s Cyramza Receives Fourth FDA Approval

    On Friday, US health regulators handed out a fourth indication to Eli Lilly and Company’s Cyramza (ramucirumab), significantly extending its patient reach. The company announced that the US Food and Drug Administration (FDA) approved Cyramza in combination with Folfiri chemotherapy for treatment of patients with metastatic colorectal cancer (mCRC) with …